Zenabis Global’s (TSX:ZENA) cultivation output in August 2019 was 1,996 kg of dried cannabis, 40.9% greater than its revised design capacity and 26.4% greater than its Aug. 6 revised forecast output of 1,579 kg of dried...
Zenabis Global’s (TSX:ZENA) cultivation output in July 2019 was 1,238 kg of dried cannabis, which represents a 46.2% outperformance relative to original design capacity and a 12.9% outperformance relative to revised...
Zenabis Global (TSX:ZENA) has secured a supply of cannabis-infused inputs for the production of cannabis-infused beverages and other products. Under the accord, Zenabis will provide cannabis to anunnamed beverage...
Zenabis Global (TSX:ZENA) posted second quarter gross revenue of $26.5-million, an increase of 115%, from $12.3-million in the first quarter of 2019. “We executed at or above plan in the second quarter and, in so...
Zenabis Global (TSX:ZENA) received a cultivation license from Health Canada for its Zenabis Langley plant, adding 9,900 kg of licensed annual cultivation capacity of cannabis at Site A – Part 1 at the facility. The...
Zenabis Global (TSX:ZENA) entered into an agreement whereby Starseed Medicinal would advance $10-million to Zenabis in September 2019 in return for dried cannabis flower and trim from Zenabis. Under the accord, Zenabis...
GMP Securities added Zenabis Global (TSX:ZENA) to its Best Ideas list, saying its sees the company becoming a top five Canadian licensed producer of cannabis but with a valuation well below most of its peers. Analyst...
By Len Zehr Despite being a new entrant in the cannabis market, Zenabis Global (TSX:ZENA) is making huge strides to become one of the largest licensed producers of medical and adult-use recreational cannabis in Canada...
Zenabis Global (TSXV:ZENA) provide an update on its recent cannabis production figures, anticipated future harvests, facility construction and licensing status, and medical program update.